REG - Hikma Pharmaceutical - Block listing Interim Review <Origin Href="QuoteRef">HIK.L</Origin>
RNS Number : 4241BHikma Pharmaceuticals Plc03 April 2017Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 3 April 2017
Name of applicant:
Hikma Pharmaceuticals PLC
Name of scheme:
Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
&
Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
&
Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
&
Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
Period of return
From:
1 October 2016
To:
31 March 2017
Balance of unallotted securities under scheme(s) from previous return:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 305,031 ordinary shares of 10 pence
MIP: 111,007 ordinary shares of 10 pence
EIP: 0 ordinary shares of 10 pence
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
SOP: 0 ordinary shares of 10 pence
LTIP: 121,000 ordinary shares of 10 pence
MIP: 200,000 ordinary shares of 10 pence
EIP: 379,000 ordinary shares of 10 pence
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
SOP: 0 ordinary shares of 10 pence
LTIP: 35,940 ordinary shares of 10 pence
MIP: 393 ordinary shares of 10 pence
EIP: 14,394 ordinary shares of 10 pence
Equals: Balance under scheme(s) not yet issued/allotted at end of period:
SOP: 792,700 ordinary shares of 10 pence
LTIP: 390,091 ordinary shares of 10 pence
MIP: 310,614 ordinary shares of 10 pence
EIP: 364,606 ordinary shares of 10 pence
Name of contact:
Peter Speirs
Telephone number of contact:
0207 399 2772
Stock Option Plan ("SOP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2016
-
-
792,700
Blocklisting return on 01/10/16
01/04/2017
-
-
792,700
Blocklisting return on 01/04/17
Long Term Incentive Plan ("LTIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2016
-
-
305,031
Blocklisting return on 01/04/16
10/10/2016
0
6,463
298,568
23/10/2016
121,000
0
419,568
08/11/2016
0
5,565
414,003
10/11/2016
0
7,964
411,147
14/11/2016
0
6,463
399,576
09/01/2017
0
5,000
394,576
17/03/2017
0
4,485
390,091
01/04/2017
-
-
390,091
Blocklisting return on 01/04/17
Management Incentive Plan ("MIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2016
-
-
111,007
Blocklisting return on 01/10/16
23/10/2016
200,000
0
311,007
16/02/2016
0
393
310,614
01/04/2017
-
-
310,614
Blocklisting return on 01/04/17
Executive Incentive Plan ("EIP")
Date
Block Listing
Shares Issued
Balance (Headroom)
Notes
01/10/2016
-
-
111,007
23/10/2016
379,000
0
379,000
04/01/2017
0
7,775
371,225
05/01/2017
0
3,713
367,512
17/02/2017
0
2,906
364,606
01/04/2017
-
-
364,606
Blocklisting return 01/04/17
This information is provided by RNSThe company news service from the London Stock ExchangeENDBLRUGUWACUPMGCW
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
AnnouncementREG - Hikma Pharmaceutical - Transaction in Own Shares
Announcement